CI

At a glance

ClinicalIndex Comparison Record
Early Ph 1Completed· 20 enrolled
Drug / intervention
Lidocaine gel +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03680885
NCT03680885Early Ph 1Completed
CompareCT.gov

Reliability Testing of a Non-invasive, Pain-free, Taste-based Assessment Approach to Lidocaine Effectiveness

PhenoSolve, LLC·interventional·Posted Sep 21, 2018·Updated Jul 15, 2020

In Brief

A Early Phase 1 clinical trial evaluating Lidocaine gel, Placebo, and 1 other intervention for ADHD and Controls. Completed, enrolled 20 participants across 1 site.

Detailed Summary

This work will assess the reliability of a simple painless test for the effectiveness of the commonly used local anesthetic lidocaine

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsADHD, Controls
CountriesUnited States
CollaboratorsJacobi Medical Center

Timeline

Early Ph 1CompletedFinished
20192020202120222023202420252026
First PostedSep 21, 2018
Enrollment StartAug 1, 2019
Primary CompletionMar 30, 2020
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 7.8 years ago

Interventions

Lidocaine geldrug

Lidocaine gel 5%, PEG with FD\&C Blue No.1 (Brilliant Blue FCF)

Placebodrug

PEG with FD\&C Blue No.1 (Brilliant Blue FCF)

Injected lidocainedrug

Standard FDA-approved dental injectable lidocaine